O
1.06
-0.79 (-42.70%)
| Previous Close | 1.85 |
| Open | 1.25 |
| Volume | 5,864,301 |
| Avg. Volume (3M) | 84,252 |
| Market Cap | 1,648,316 |
| Price / Earnings (TTM) | 0.001 |
| Price / Sales | 0.700 |
| Price / Book | 0.690 |
| 52 Weeks Range | |
| Earnings Date | 27 Aug 2025 - 31 Aug 2025 |
| Operating Margin (TTM) | -1,626.32% |
| Diluted EPS (TTM) | -161.50 |
| Quarterly Revenue Growth (YOY) | -85.50% |
| Total Debt/Equity (MRQ) | 200.26% |
| Current Ratio (MRQ) | 0.170 |
| Operating Cash Flow (TTM) | -7.26 M |
| Levered Free Cash Flow (TTM) | -3.13 M |
| Return on Assets (TTM) | -8.25% |
| Return on Equity (TTM) | -201.34% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Onconetix, Inc. | - | - |
AIStockmoo Score
-0.1
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.13 |
|
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men’s health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 57.97% |
| % Held by Institutions | 0.82% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Pacific Capital Wealth Advisors, Inc. | 31 Dec 2025 | 0 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |